Cargando…
Immune deviation and cervical carcinogenesis
Evidence is emerging that a complex interplay between high-risk human papillomavirus infection, the local microenvironment and the immune system is critical for cervical carcinogenesis. To establish persistence, the virus has to evade or overcome immune control. At the transition from precancer to c...
Autor principal: | Smola, Sigrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477167/ https://www.ncbi.nlm.nih.gov/pubmed/30980967 http://dx.doi.org/10.1016/j.pvr.2019.03.006 |
Ejemplares similares
-
RIPK3—a predictive marker for personalized immunotherapy?
por: Smola, Sigrun
Publicado: (2015) -
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
por: Smola, Sigrun
Publicado: (2017) -
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review
por: Mehta, Akash M., et al.
Publicado: (2017) -
Clonal status and clinicopathological observation of cervical minimal deviation adenocarcinoma
por: Gong, Li, et al.
Publicado: (2010) -
Implications of tyrosine phosphoproteomics in cervical carcinogenesis
por: Robinson-Bennett, Bernice L, et al.
Publicado: (2008)